1. Home
  2. GH vs STE Comparison

GH vs STE Comparison

Compare GH & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

SELL

Current Price

$158.26

Market Cap

22.9B

Sector

Health Care

ML Signal

SELL

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

SELL

Current Price

$222.40

Market Cap

21.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GH
STE
Founded
2011
1985
Country
United States
United States
Employees
N/A
3700
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
21.3B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
GH
STE
Price
$158.26
$222.40
Analyst Decision
Strong Buy
Buy
Analyst Count
26
9
Target Price
$201.64
★ $262.14
AVG Volume (30 Days)
★ 1.8M
594.2K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 1.23%
EPS Growth
6.74
★ 27.90
EPS
N/A
★ 7.93
Revenue
$982,021,000.00
★ $5,935,900,000.00
Revenue This Year
$38.42
$7.35
Revenue Next Year
$35.13
$6.36
P/E Ratio
★ N/A
$28.21
Revenue Growth
★ 32.88
8.73
52 Week Low
$65.96
$195.14
52 Week High
$191.05
$269.44

Technical Indicators

Market Signals
Indicator
GH
STE
Relative Strength Index (RSI) 38.93 60.32
Support Level $153.88 $216.22
Resistance Level $173.94 $227.10
Average True Range (ATR) 8.16 4.32
MACD -2.16 2.08
Stochastic Oscillator 1.83 75.07

Price Performance

Historical Comparison
GH
STE

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Share on Social Networks: